Scientists described an anti-HLA-A2 CAR generated by grafting the complementarity-determining regions of a human monoclonal anti-HLA-A2 antibody into the framework regions of the Herceptin 4D5 single-chain variable fragment and fusing it with a CD28-ζ signaling domain.
[Frontiers in Immunology]
6445218
{6445218:AAAAAAAA}
apa
50
1
166999
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
